Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Pregnancy outcome in fetuses with increased nuchal translucency

Abstract

Objective:

The aim of this study was to examine fetal and neonatal outcomes in the setting of nuchal translucency (NT) 3 mm at routine first-trimester screening.

Study Design:

A nested case-series study within a retrospective cohort of women screened for Down syndrome at 11–14 weeks of gestation. Crown-rump length, NT values and additional anomalies at first and early second trimesters were recorded. Follow-up information was obtained by a review of medical records and self-report from patients. Adverse outcomes included fetal death and termination of pregnancy due to structural or chromosomal anomalies.

Result:

A total of 1930 pregnant women were screened between 11 and 14 weeks of gestation. The prevalence of increased fetal NT (3 mm) was 1.4% (n=27). Among these, 12 showed increased fetal NT as an isolated finding. In this group, 2 women experienced fetal demise (16%) and 10 delivered healthy babies. In the group with additional abnormalities (n=15), 9 (60%) were found to have chromosomal abnormalities, all of which were terminated. For all cases with increased fetal NT, total incidence of adverse outcome was 62%.

Conclusion:

At first-trimester ultrasonography, a fetal NT 3 mm was associated with a high incidence of chromosomal abnormalities in the presence of associated abnormalities. For cases with the increased fetal NT at first-trimester fetal assessment and follow-up is necessary to detect possible adverse outcomes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Pandya PP, Santiago C, Snijders RJ, Nicolaides KH . First trimester fetal nuchal translucency. Curr Opin Obstet Gynecol 1995; 7: 95–102.

    Article  CAS  Google Scholar 

  2. Comstock C, Malone F, Ball RH, Nyberg DA, Saade GR, Berkowitz RL et al. Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening? Am J Obstet Gynecol 2006; 195: 843–847.

    Article  Google Scholar 

  3. Nicolaides KH, Wegrzyn P . Increased nuchal translucency with normal karyotype. Ginekol Pol 2005; 76: 593–601.

    PubMed  Google Scholar 

  4. Pandya PP, Kondylios A, Hilbert L, Snijders RJ, Nicolaides KH . Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 1995; 5: 15–19.

    Article  CAS  Google Scholar 

  5. Cha’ban FK, Van Splunder P, Los FJ, Wladimiroff JW . Fetal outcome in nuchal translucency with emphasis on normal karyotype. Prenat Diagn 1996; 16: 537–541.

    Article  Google Scholar 

  6. Bilardo CM, Pajkrt E, de Graaf I, Mol BW, Bleker OP . Outcomes of fetuses with enlarged nuchal translucency and normal karyotype. Ultrasound Obstet Gynecol 1998; 11: 401–406.

    Article  CAS  Google Scholar 

  7. Cheng CC, Bahado-Singh RO, Chen SC, Tsai MS . Pregnancy outcomes with increased nuchal translucency after routine Down syndrome screening. Int J Gynaecol Obstet 2004; 84: 5–9.

    Article  Google Scholar 

  8. Weisz B, Pandya PP, David AL, Huttly W, Jones P, Rodeck CH . Ultrasound findings after screening for Down syndrome using the integrated test. Obstet Gynecol 2007; 109: 1046–1052.

    Article  Google Scholar 

  9. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K . Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992; 304: 867–869.

    Article  CAS  Google Scholar 

  10. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005; 353: 2001–2011.

    Article  CAS  Google Scholar 

  11. Hyett J, Moscoso G, Papapanagiotou G, Perdu M, Nicolaides KH . Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11–13 weeks of gestation. Ultrasound Obstet Gynecol 1996; 7: 245–250.

    Article  CAS  Google Scholar 

  12. Rizzo G, Muscatello A, Angelini E, Capponi A . Abnormal cardiac function in fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 2003; 21: 539–542.

    Article  CAS  Google Scholar 

  13. Mavrides E, Cobian-Sanchez F, Tekay A, Moscoso G, Campbell S, Thilaganathan B et al. Limitations of using first trimester nuchal translucency measurements in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol 2001; 17: 106–110.

    Article  CAS  Google Scholar 

  14. Senat MV, De Keersmaecker B, Audibert F, Montcharmont G, Frydman R, Ville Y . Pregnancy outcome in fetuses with increased nuchal translucency and normal karyotype. Prenat Diagn 2002; 22: 345–349.

    Article  CAS  Google Scholar 

  15. Nyberg DA, Luthy DA, Resta RG, Nyberg BC, Williams MA . Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases. Ultrasound Obstet Gynecol 1998; 12: 8–14.

    Article  CAS  Google Scholar 

  16. Brown DL, Roberts DJ, Miller WA . Left ventricular echogenic focus in the fetal heart: pathologic correlation. J Ultrasound Med 1994; 13: 613–616.

    Article  CAS  Google Scholar 

  17. Roberts DJ, Genest D . Cardiac histologic pathology characteristic of trisomies 13 and 21. Hum Pathol 1992; 23: 1130–1140.

    Article  CAS  Google Scholar 

  18. Prefumo F, Presti F, Thilaganathan B, Carvalho JS . Association between increased nuchal translucency and second trimester cardiac echogenic foci. Obstet Gynecol 2003; 101: 899–904.

    PubMed  Google Scholar 

  19. Shah YG, Eckl CJ, Stinson SK, Woods Jr JR . Biparietal diameter/femur length ratio, cephalic index, and femur length measurements: not reliable screening techniques for Down syndrome. Obstet Gynecol 1990; 75: 186–188.

    CAS  PubMed  Google Scholar 

  20. Hyett J, Noble P, Sebire NJ, Snijders R, Nicolaides KH . Lethal congenital arthrogryposis presents with increased nuchal translucency at 10–14 weeks of gestation. Ultrasound Obstet Gynecol 1997; 9: 310–313.

    Article  CAS  Google Scholar 

  21. Malone FD, Ball RH, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL et al. First-trimester septated cystic hygroma: prevalence, natural history and pediatric outcome. Obstet Gynecol 2005; 106: 288–294.

    Article  Google Scholar 

  22. Molina FS, Avgidou K, Kagan KO, Poggi S, Nicolaides KH . Cystic hygromas, nuchal edema, and nuchal translucency at 11–14 weeks of gestation. Obstet Gynecol 2006; 107: 678–683.

    Article  Google Scholar 

  23. Cicero S, Sonek JD, McKenna DS, Croom CS, Johnson L, Nicolaides KH . Nasal bone hypoplasia in trisomy 21 at 15–22 weeks’ gestation. Ultrasound Obstet Gynecol 2003; 21: 15–18.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C Dane.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dane, B., Dane, C., Cetin, A. et al. Pregnancy outcome in fetuses with increased nuchal translucency. J Perinatol 28, 400–404 (2008). https://doi.org/10.1038/jp.2008.14

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2008.14

Keywords

Search

Quick links